AYTU vs NVR · rev $66.4M vs P/E 15, rev $4.21B
Aytu BioScience Inc (AYTU) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
AYTU currently screens at market cap $24.1M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the AYTU and NVR stock pages for the full models.
Not investment advice.